Advances in coronary angioplasty

New England Journal of Medicine

Volumn 335, Issue 17, 1996, Pages 1290-1302

  Bittl, John A ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; HEPARIN; UROKINASE;

ATHERECTOMY; CORONARY ARTERY DILATATION; CORONARY ARTERY OBSTRUCTION; FIBRINOLYTIC THERAPY; HEPARINIZATION; HUMAN; LASER ANGIOPLASTY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; RESTENOSIS; REVIEW; STENT;

ANGIOPLASTY, LASER; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY DISEASE; HUMANS; MYOCARDIAL REVASCULARIZATION; STENTS; THROMBOLYTIC THERAPY;

EID: 0029911150     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199610243351707     Document Type: Review

References (97)

1. Ellis SG, Omoigui N, Bittl JA, et al. Analysis and comparison of operator-specific outcomes in interventional cardiology: from a multicenter database of 4860 quality-controlled procedures. Circulation 1996;93:431-9.
2. Wolte MW, Roubin GS, Schweiger M, et al. Length of hospital stay and complications after percutaneous transluminal coronary angioplasty: clinical and procedural predictors. Circulation 1995;92:311-9.
3. Topol EJ, Leya F, Pinkerton CA, et al. A comparison of directional atherectomy with coronary angioplasty in patients with coronary artery disease. N Engl J Med 1993;329:221-7.
4. Adelman AG, Cohen EA, Kimball BP, et al. A comparison of directional atherectomy with balloon angioplasty for lesions of the left anterior descending coronary artery. N Engl J Med 1993;329:228-33.
5. Serruys PW, de Jaegere P, Kiemeneij F, et al. A comparison of balloon-expandable - stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med 1994;331:489-95.
6. Fischman DL, Leon MB, Baim DS, et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med 1994;331:496-501.
7. Ellis SG, Cowley MJ, Whitlow PL, et al. Prospective case-control comparison of percutaneous transluminal coronary revascularization in patients with multivessel disease treated in 1986-1987 versus 1991: improved in-hospital and 12-month results. J Am Coll Cardiol 1995;25: 1137-42.
8. Detre K, Holubkov R, Kelsey S, et al. Percutaneous transluminal coronary angioplasty in 1985-1986 and 1977-1981: the National Heart, Lung, and Blood Institute Registry. N Engl J Med 1988;318:265-70.
9. Nobuyoshi M, Kimura T, Nosaka H, et al. Restenosis after successful percutaneous transluminal coronary angioplasty: serial angiographic follow-up of 229 patients. J Am Coll Cardiol 1988;12:616-23.
10. The EPIC Investigators. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. N Engl J Med 1994;330:956-61.
11. Topol EJ, Califf RM, Weisman HF, et al. Randomised trial of coronary intervention with antibody against platelet IIb/IIIa integrin for reduction of clinical restenosis: results at six months. Lancet 1994;343:881-6.
12. Topol EJ. Evaluation of PTCA to Improve Long-Term Outcomes with c7E3 Glycoprotein IIb/IIIa-Receptor Blockade (EPILOG). Presented at the Scientific Sessions of the European Society of Cardiology, Birmingham, England, August 27, 1996.
13. Landau C, Lange RA, Hillis LD. Percutaneous transluminal coronary angioplasty. N Engl J Med 1994;330:981-93.
14. Lemaitre DT, Barber AP, Mullen MG. Interventional cardiology. The Cowen Report. March 6, 1996:1-32.
15. Kuntz RE, Gibson CM, Nobuyoshi M, Baim DS. Generalized model of restenosis after conventional balloon angioplasty, stenting and directional atherectomy. J Am Coll Cardiol 1993;21:15-25.
16. Roubin GS, Douglas JS Jr, King SB III, et al. Influence of balloon size on initial success, acute complications, and restenosis after percutaneous transluminal coronary angioplasty: a prospective randomized study. Circulation 1988;78:557-65.
17. Holmes DR Jr, Topol EJ, Califf RM, et al. A multicenter, randomized trial of coronary angioplasty versus directional atherectomy for patients with saphenous vein bypass graft lesions: CAVEAT-II Investigators. Circulation 1995;91:1966-74.
18. Appelman YEA, Piek JJ, Strikwerda S, et al. Randomised trial of excimer laser angioplasty versus balloon angioplasty for treatment of obstructive coronary artery disease. Lancet 1996;347:79-84.
19. Appelman YEA, Koolen JJ, Piek JJ, et al. Excimer laser angioplasty versus balloon angioplasty in functional and total coronary occlusions. Am J Cardiol 1996;78:757-62.
20. Bittl JA. Directional coronary atherectomy versus balloon angioplasty. N Engl J Med 1993;329:273-4.
21. Harrington RA, Lincoff AM, Califf RM, et al. Characteristics and consequences of myocardial infarction after percutaneous coronary intervention: insights from the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT). J Am Coll Cardiol 1995;25:1693-9.
22. Elliott JM, Berdan LG, Holmes DR, et al. One-year follow-up in the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT I). Circulation 1995;91:2158-66.
23. Baim DS, Simonton CA, Popma JJ, et al. Mechanism of lumen enlargement by optimal atherectomy - IVUS insights from the OARS Study. J Am Coll Cardiol 1996;27:Suppl A:291A. abstract.
24. Mintz GS, Kovach JA, Javier SP, et al. Mechanisms of lumen enlargement after excimer laser coronary angioplasty: an intravascular ultrasound study. Circulation 1995;92:3408-14.
25. Baumbach A, Bittl JA, Fleck E, et al. Acute complications of excimer laser coronary angioplasty: a detailed analysis of multicenter results. J Am Coll Cardiol 1994;23:1305-13.
26. Bittl JA, Ryan TJ Jr, Keaney JF Jr, et al. Coronary artery perforation during excimer laser coronary angioplasty. J Am Coll Cardiol 1993;21: 1158-65.
27. van Leeuwen TG, Meertens JH, Velema E, Post MJ, Borst C. Intraluminal vapor bubble induced by excimer laser pulse causes microsecond arterial dilation and invagination leading to extensive wall damage in the rabbit. Circulation 1993;87:1258-63.
28. Deckelbaum LI, Natarajan MK, Bittl JA, et al. Effect of intracoronary saline infusion on dissection during excimer laser coronary angioplasty: a randomized trial. J Am Coll Cardiol 1995;26:1264-9.
29. Safian RD, Niazi KA, Strzelecki M, et al. Detailed angiographic analysis of high-speed mechanical rotational atherectomy in human coronary arteries. Circulation 1993;88:961-8.
30. MacIsaac AI, Bass TA, Buchbinder M, et al. High speed rotational atherectomy: outcome in calcified and noncalcified coronary artery lesions. J Am Coll Cardiol 1995;26:731-6.
31. Vandormael M, Reifart N, Preusler W, et al. Six months follow-up results following excimer laser angioplasty, rotational atherectomy and balloon angioplasty for complex lesions: ERBAC Study. Circulation 1994;90: Suppl:I-213. abstract.
32. de Muinck ED, den Heijer P, van Dijk RB, et al. Autoperfusion balloon versus stent for acute or threatened closure during percutaneous transluminal coronary angioplasty. Am J Cardiol 1994;74:1002-5.
33. Lincoff AM, Topol EJ, Chapekis AT, et al. Intracoronary stenting compared with conventional therapy for abrupt vessel closure complicating coronary angioplasty: a matched case-control study. J Am Coll Cardiol 1993; 21:866-75.
34. Roubin GS, Cannon AD, Agrawal SK, et al. Intracoronary stenting for acute and threatened closure complicating percutaneous transluminal coronary angioplasty. Circulation 1992;85:916-27.
35. Lincoff AM, Popma JJ, Ellis SG, Hacker JA, Topol EJ. Abrupt vessel closure complicating coronary angioplasty: clinical, angiographic and therapeutic profile. J Am Coll Cardiol 1992;19:926-35.
36. White CJ, Ramee SR, Collins TJ, Jain SP, Escobar A. Coronary angioscopy of abrupt occlusion after angioplasty. J Am Coll Cardiol 1995;25: 1681-4.
37. Sutton JM, Ellis SG, Roubin GS, et al. Major clinical events after coronary stenting: the multicenter registry of acute and elective Gianturco-Roubin stent placement. Circulation 1994;89:1126-37.
38. Hasdai D, Garratt KN, Holmes DR Jr, Berger PB, Schwartz RS, Bell MR. Coronary angioplasty and intracoronary thrombolytics are of limited efficacy in resolving early intracoronary stent thrombosis. J Am Coll Cardiol 1996;28:361-7.
39. Macaya C, Serruys PW, Ruygrok P, et al. Continued benefit of coronary stenting versus balloon angioplasty: one-year clinical follow-up of Benestent trial. J Am Coll Cardiol 1996;27:255-61.
40. Kimura T, Yokoi H, Nakagawa Y, et al. Three-year follow-up after implantation of metallic coronary-artery stents. N Engl J Med 1996;334:561-6.
41. Itoh A, Colombo A, Hall P, et al. Stenting in protected and unprotected left main coronary artery: immediate and follow-up results. J Am Coll Cardiol 1996;27:Suppl A:277A. abstract.
42. Piana RN, Moscucci M, Cohen DJ, et al. Palmaz-Schatz stenting for treatment of focal vein graft stenosis: immediate results and long-term outcome. J Am Coll Cardiol 1994;23:1296-304.
43. Wong SC, Baim DS, Schatz RS, et al. Immediate results and late outcomes after stent implantation in saphenous vein graft lesions: the multicenter U.S. Palmaz-Schatz stent experience. J Am Coll Cardiol 1995;26: 704-12.
44. Goldberg SL, Colombo A, Maiello L, Borrione M, Finci L, Almagor Y. Intracoronary stent insertion after balloon angioplasty of chronic total occlusions. J Am Coll Cardiol 1995;26:713-9.
45. Serruys PW, Leon M, Hamburger JN, et al. Recanalization of chronic total coronary occlusions using a laser guide wire: the EU and US TOTAL experience. J Am Coll Cardiol 1996;27:Suppl A:152A. abstract.
46. Popma JJ, Coller BS, Ohman EM, et al. Antithrombotic therapy in patients undergoing coronary angioplasty. Chest 1995;108:Suppl:486S-501S.
47. Mak K-H, Belli G, Ellis SG, Moliterno DJ. Subacute stent thrombosis: evolving issues and current concepts. J Am Coll Cardiol 1996;27:494-503.
48. Bittl JA. Subacute stent occlusion: thrombus horribilis. J Am Coll Cardiol 1996;28:368-70.
49. Colombo A, Hall P, Nakamura S, et al. Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance. Circulation 1995;91:1676-88.
50. Neumann F-J, Gawaz M, Ott I, May A, Mössmer G, Schömig A. Prospective evaluation of hemostatic predictors of subacute stent thrombosis after coronary Palmaz-Schatz stenting. J Am Coll Cardiol 1996;27:15-21.
51. Schömig A, Neumann F-J, Kastrati A, et al. A randomized comparison of antiplatelet and anticoagulation therapy after the placement of coronary-artery stents. N Engl J Med 1996;334:1084-9.
52. Serruys PW, Emanuelsson H, van der Giessen W, et al. Heparin-coated Palmaz-Schatz stents in human coronary arteries: early outcome of the Benestent-II Pilot Study Circulation 1996;93:412-22.
53. Rogers C, Edelman ER. Endovascular stent design dictates experimental restenosis and thrombosis. Circulation 1995;91:2995-3001.
54. Currier JW, Faxon DP. Restenosis after percutaneous transluminal coronary angioplasty: have we been aiming at the wrong target? J Am Coll Cardiol 1995;25:516-20.
55. O'Brien ER, Alpers CE, Stewart DK, et al. Proliferation in primary and restenotic coronary atherectomy tissue: implications for antiproliferative therapy. Circ Res 1993;73:223-31.
56. Mintz GS, Popma JJ, Pichard AD, et al. Intravascular ultrasound predictors of restenosis after percutaneous transcatheter coronary revascularization. J Am Coll Cardiol 1996;27:1678-87.
57. Idem. Arterial remodeling after coronary angioplasty: a serial intravascular ultrasound study. Circulation 1996;94:35-43.
58. Glagov S, Weisenberg E, Zarins CK, Stankunavicius R, Kolettis GJ. Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med 1987;316:1371-5.
59. Kakuta T, Currier JW, Haudenschild CC, Ryan TJ, Faxon DP Differences in compensatory vessel enlargement, not intimal formation, account for restenosis after angioplasty in the hypercholesterolemic rabbit model. Circulation 1994;89:2809-15.
60. Strauss BH, Chisholm RJ, Keeley FW, Gotlieb AI, Logan RA, Armstrong PW. Extracellular matrix remodeling after balloon angioplasty injury in a rabbit model of restenosis. Circ Res 1994;75:650-8.
61. Dussaillant GR, Mintz GS, Pichard AD, et al. Small stent size and intimal hyperplasia contribute to restenosis: a volumetric intravascular ultrasound analysis. J Am Coll Cardiol 1995;26:720-4.
62. Fernández-Ortiz A, Badimon JJ, Falk E, et al. Characterization of the relative thrombogenicity of atherosclerotic plaque components: implications for consequences of plaque rupture. J Am Coll Cardiol 1994;23:1562-9.
63. Merino A, Cohen M, Badimon JJ, Fuster V, Badimon L. Synergistic action of severe wall injury and shear forces on thrombus formation in arterial stenosis: definition of a thrombotic shear rate threshold. J Am Coll Cardiol 1994;24:1091-7.
64. Marmur JD, Merlini PA, Sharma SK, et al. Thrombin generation in human coronary arteries after percutaneous transluminal balloon angioplasty. J Am Coll Cardiol 1994;24:1484-91.
65. Coughlin SR, Vu TK, Hung DT, Wheaton VI. Characterization of a functional thrombin receptor: issues and opportunities. J Clin Invest 1992; 89:351-5.
66. Hirsh J, Fuster V. Guide to anticoagulant therapy. I. Heparin. Circulation 1994;89:1449-68.
67. Serruys PW, Herrman J-PR, Simon R, et al. A comparison of hirudin with heparin in the prevention of restenosis after coronary angioplasty. N Engl J Med 1995;333:757-63.
68. Bittl JA, Strony J, Brinker JA, et al. Treatment with bivalirudin (Hirulog) as compared with heparin during coronary angioplasty for unstable or postinfarction angina. N Engl J Med 1995;333:764-9.
69. Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med 1992;326:242-50, 310-8.
70. Tcheng JE, Lincoff AM, Sigmon KN, Califf RM, Topol EJ. Platelet glycoprotein IIb/IIIa inhibition with Integrelin during percutaneous coronary intervention: the IMPACT II Trial. Circulation 1995;92:Suppl I:I-543, abstract.
71. Horrigan MCG, Tcheng JE, Califf RM, et al. Maximal benefit of Integrelin platelet IIb/IIIa blockade 6-12 hours after therapy: results of the IMPACT-II Trial. J Am Coll Cardiol 1996;27:Suppl A:55A. abstract.
72. Ambrose JA, Almeida OD, Sharma SK, et al. Adjunctive thrombolytic therapy during angioplasty for ischemic rest angina: results of the TAUSA Trial. Circulation 1994;90:69-77.
73. The TIMI IIIB Investigators. Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction: results of the TIMI IIIB Trial. Circulation 1994;89:1545-56.
74. Eisenberg PR, Sobel BE, Jaffe AS. Activation of prothrombin accompanying thrombolysis with recombinant tissue-type plasminogen activator. J Am Coll Cardiol 1992;19:1065-9.
75. Parisi AF, Folland ED, Hartigan P A comparison of angioplasty with medical therapy in the treatment of single-vessel coronary artery disease. N Engl J Med 1992;326:10-6.
76. Hueb WA, Bellotti G, de Oliveira SA, et al. The Medicine, Angioplasty, or Surgery Study (MASS): a prospective, randomized trial of medical therapy, balloon angioplasty or bypass surgery for single proximal left anterior descending artery stenoses. J Am Coll Cardiol 1995;26:1600-5.
77. Anderson HV, Cannon CP, Stone PH, et al. One-year results of the Thrombolysis in Myocardial Infarction (TIMI) IIIB clinical trial: a randomized comparison of tissue-type plasminogen activator versus placebo and early invasive versus early conservative strategies in unstable angina and non-Q wave myocardial infarction. J Am Coll Cardiol 1995;26:1643-50.
78. Michels KB, Yusuf S. Does PTCA in acute myocardial infarction affect mortality and reinfarction rates? A quantitative overview (meta-analysis) of the randomized clinical trials. Circulation 1995;91:476-85.
79. Every NR, Parsons LS, Hlatky M, Martin JS, Weaver WD. A comparison of thrombolytic therapy with primary coronary angioplasty for acute myocardial infarction. N Engl J Med 1996;335:1253-60.
80. Pocock SJ, Henderson RA, Rickards AF, et al. Meta-analysis of randomised trials comparing coronary angioplasty with bypass surgery. Lancet 1995;346:1184-9.
81. The Bypass Angioplasty Revascularization Investigation (BARI) Investigators. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. N Engl J Med 1996;335:217-25.
82. Hamm CW, Reimers J, Ischinger T, Rupprecht H-J, Berger J, Bleifield W. A randomized study of coronary angioplasty compared with bypass surgery in patients with symptomatic multivessel coronary disease. N Engl J Med 1994;331:1037-43.
83. King SB III, Lembo NJ, Weintraub WS, et al. A randomized trial comparing coronary angioplasty with coronary bypass surgery. N Engl J Med 1994;331:1044-50.
84. RITA Trial Participants. Coronary angioplasty versus coronary artery bypass surgery: the Randomised Intervention Treatment of Angina (RITA) trial. Lancet 1993;341:573-80.
85. Aronson D, Bloomgarden Z, Rayfield EJ. Potential mechanisms promoting restenosis in diabetic patients. J Am Coll Cardiol 1996;27:528-35.
86. Brown G, Albers JJ, Fisher LD, et al. Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B. N Engl J Med 1990;323:1289-98.
87. Weintraub WS, Boccuzzi SJ, Klein JL, et al. Lack of effect of lovastatin on restenosis after coronary angioplasty. N Engl J Med 1994;331:1331-7.
88. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344:1383-9.
89. Sacks FM, Pfeffer MA, Moye LA, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med 1996;335:1001-9.
90. Treasure CB, Klein JL, Weintraub WS, et al. Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease. N Engl J Med 1995;332:481-7
91. Anderson TJ, Meredith IT, Yeung AC, Frei B, Selwyn AP, Ganz P. The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion. N Engl J Med 1995;332:488-93.
92. Ambrose JA, Tannenbaum MA, Alexopoulos D, et al. Angiographic progression of coronary artery disease and the development of myocardial infarction. J Am Coll Cardiol 1988;12:56-62.
93. Little WC, Constantinescu M, Applegate RJ, et al. Can coronary angiography predict the site of a subsequent myocardial infarction in patients with mild-to-moderate coronary artery disease? Circulation 1988;78:1157-66.
94. Uren NG, Melin JA, De Bruyne B, Wijns W, Baudhuin T, Camici PG. Relation between myocardial blood flow and the severity of coronary-artery stenosis. N Engl J Med 1994;330:1782-8.
95. Mintz GS, Painter JA, Pichard AD, et al. Atherosclerosis in angiographically "normal" coronary artery reference segments: an intravascular ultrasound study with clinical correlations. J Am Coll Cardiol 1995;25: 1479-85.
96. Topol EJ, Nissen SE. Our preoccupation with coronary luminology: the dissociation between clinical and angiographic findings in ischemic heart disease. Circulation 1995;92:2333-42.
97. The GUIDE Trial Investigators. IVUS-determined predictors of restenosis in PTCA and DCA: final report from the GUIDE Trial, Phase II. J Am Coll Cardiol 1996;27:Suppl A:156A. abstract.